Downstate Medical Center
Advanced Biotechnology Incubator is the cornerstone of an ambitious,
borough-wide initiative to transform Brooklyn into a center for biotech research and development.
To meet the high demand for affordable biotech space, SUNY Downstate Medical Center is
creating a vibrant, urban Biotechnology Park adjacent to its current facilities.
a first step, the Park’s anchor tenant ImClone Systems has constructed a 13,000
sq. ft. satellite facility. Adjacent to ImClone, Downstate is building a 50,000
sq. ft. Advanced Biotechnology Incubator to provide laboratory space for 20 to
30 companies. A total of $12 million has been raised from government and
private sources to construct the facility’s first two phases. The first phase
is complete and companies have begun leasing space. The second phase will be
finished in summer 2004.
the biotech companies grow, they can expand into low-cost industrial Empire
Zones in Brooklyn. To facilitate this effort the Brooklyn Biotechnology
Consortium was formed, which includes: Brooklyn Economic Development Corp.,
Brooklyn Borough President’s Office, Brooklyn Chamber of Commerce, Brooklyn
Empire Zones, New York City Economic Development Corp., Empire State
Development Corp., New York Biotechnology Association, Pfizer, Con Edison and KeySpan.
develop a well-educated local labor force, job-training programs in
biotechnology are being developed for graduate students and technicians. In
addition, a special program for Brooklyn teachers will be implemented to introduce
biotechnology and related career opportunities to high school students.
complete, Downstate Medical Center’s Advanced Biotechnology Incubator and the
neighboring biotech facilities are expected to stimulate Brooklyn’s
economic revitalization through business growth and job creation, and help
ensure that technologies developed in New
York remain in New York.
Eva Brown Cramer, Vice President for
Biotechnology and Scientific Affairs, is overseeing the creation of the Biotech Park adjacent
to Downstate Medical Center. Dr. Cramer helped raise private, city, state and
federal funds for the first 24,000 sq. ft. of a 50,000 sq. ft. Advanced
Biotechnology Incubator building. In addition, Dr. Cramer attracted an anchor
tenant, ImClone Systems, and helped form then Brooklyn Biotech Consortium to
facilitate biotechnology manufacturing throughout the borough.
Systems Inc., Downstate’s anchor
tenant, has established a new $4.5 million laboratory facility within the Park
for its new Small Molecule Drug Discovery Division. Dr. Alexander Kiselyov, an
Assistant Vice President at ImClone, oversaw the building’s construction, and
directs the development of new cancer and rheumatoid arthritis drugs at this
President Marty Markowitz, whose long
career of public service includes 11 terms in the New York State
Senate, demonstrated his commitment to Brooklyn’s future prosperity through
his $1 million backing of the Biotech Incubator and has promised continued
support to help biotech grow in Brooklyn.
Sheldon Silver, D- 64th
District, and the Brooklyn Assembly Delegation clearly recognized Brooklyn’s
potential to harness biotech as an engine for growth and Downstate Medical
Center’s ability to transform that vision into reality. The forward thinking
and leadership of Speaker Silver, Assemblyman Clarence Norman Jr., D-43rd
District, and former Assemblyman William Frank Boyland Sr., D-55th
District, enabled the construction of the second phase of the Advanced
Biotechnology Incubator with a multimillion dollar capital grant. New York City
Council Speaker Gifford Miller and the Brooklyn City Council Delegation have
championed this initiative and have had a tremendously positive impact on both
local and citywide economic development. The millions of dollars they have
invested in the Advanced Biotechnology Incubator will not only stimulate local
job creation, but will help New York City to achieve its potential as a leader
Representative Major R. Owens, D-New York’s 11th District, was
instrumental in developing the vision for the Incubator and
securing the federal funding that made it possible.